Reactivation of SARS-CoV-2 infection following recovery from COVID-19

被引:11
|
作者
Chen, Zhihai [1 ]
Xie, Wen [2 ]
Ge, Ziruo [1 ,3 ]
Wang, Yajie [4 ]
Zhao, Hong [2 ]
Wang, Jingjing [2 ]
Xu, Yanli [1 ]
Zhang, Wei [1 ]
Song, Meihua [1 ]
Cui, Shuping [1 ,5 ]
Wang, Xiankun [1 ,3 ]
Pan, Calvin Q. [2 ]
机构
[1] Capital Med Univ, Beijing Ditan Hosp, Ctr Infect Dis, Beijing, Peoples R China
[2] Capital Med Univ, Beijing Ditan Hosp, Ctr Liver Dis, 8 Jingshun East St, Beijing 100015, Peoples R China
[3] Capital Med Univ, Grad Sch, Beijing, Peoples R China
[4] Capital Med Univ, Beijing Ditan Hosp, Dept Clin Lab, Beijing, Peoples R China
[5] Peking Univ, Ditan Teaching Hosp, Beijing, Peoples R China
关键词
Coronavirus reactivation; COVID-19; relapse; Persistent coronavirus infection; Real-Time reverse; transcription-polymerase chain reaction; Recurrent SARS-CoV-2 infection;
D O I
10.1016/j.jiph.2021.02.002
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Introduction: Many individuals test positive for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA after recovering from the coronavirus disease (COVID-19), but the incidence of reactivation is unknown. We, therefore, estimated the incidence of reactivation among individuals who had recovered from COVID-19 and determined its predictors. Methods: In this retrospective cohort study, patients with COVID-19 were followed up for at least 14 days after two consecutive negative SARS-CoV-2 polymerase chain reaction test results obtained >= 24 h apart, and the frequency of SARS-CoV-2 reactivation was assessed. Results: Of the 109 patients, 29 (27%) experienced reactivation, and seven (24%) of these were symp-tomatic. The mean period for the real-time PCR tests for SARS-CoV-2 from negative to positive results was 17 days. Compared with patients without reactivation, those with reactivation were significantly younger and more likely to have a lymphocyte count of <1500/mu L (odds ratio [OR]: 0.34, 95% confidence interval [CI]: 0.12-0.94) and two or fewer symptoms (OR: 0.20, 95% CI: 0.07-0.55) during the initial episode. Conclusion: Risk-stratified surveillance should be conducted among patients who have recovered from COVID-19. (c) 2021 The Authors. Published by Elsevier Ltd on behalf of King Saud Bin Abdulaziz University for Health Sciences. This is an open access article under the CC BY-NC-ND license (http://creativecommons. org/licenses/by-nc-nd/4.0/).
引用
收藏
页码:620 / 627
页数:8
相关论文
共 50 条
  • [1] SARS-CoV-2 Infection and COVID-19 in Children
    Waghmare, Alpana
    Hijano, Diego R.
    CLINICS IN CHEST MEDICINE, 2023, 44 (02) : 359 - 371
  • [2] Epidemiology of SARS-CoV-2 infection and COVID-19
    Salzberger, B.
    Buder, F.
    Lampl, B.
    Ehrenstein, B.
    Hitzenbichler, F.
    Hanses, F.
    INTERNIST, 2020, 61 (08): : 782 - 788
  • [3] Infection with SARS-CoV-2 is not the same as covid-19
    Bamji, Andrew
    BMJ-BRITISH MEDICAL JOURNAL, 2021, 374
  • [4] SARS-CoV-2 Infection and COVID-19 in Children
    Waghmare, Alpana
    Hijano, Diego R.
    RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 2025, 51 (01) : 139 - 156
  • [5] Dynamic changes in anti-SARS-CoV-2 antibodies during SARS-CoV-2 infection and recovery from COVID-19
    Li, Kening
    Huang, Bin
    Wu, Min
    Zhong, Aifang
    Li, Lu
    Cai, Yun
    Wang, Zhihua
    Wu, Lingxiang
    Zhu, Mengyan
    Li, Jie
    Wang, Ziyu
    Wu, Wei
    Li, Wanlin
    Bosco, Bakwatanisa
    Gan, Zhenhua
    Qiao, Qinghua
    Wu, Jian
    Wang, Qianghu
    Wang, Shukui
    Xia, Xinyi
    NATURE COMMUNICATIONS, 2020, 11 (01)
  • [6] Dynamic changes in anti-SARS-CoV-2 antibodies during SARS-CoV-2 infection and recovery from COVID-19
    Kening Li
    Bin Huang
    Min Wu
    Aifang Zhong
    Lu Li
    Yun Cai
    Zhihua Wang
    Lingxiang Wu
    Mengyan Zhu
    Jie Li
    Ziyu Wang
    Wei Wu
    Wanlin Li
    Bakwatanisa Bosco
    Zhenhua Gan
    Qinghua Qiao
    Jian Wu
    Qianghu Wang
    Shukui Wang
    Xinyi Xia
    Nature Communications, 11
  • [7] SARS-CoV-2 reinfection in patients negative for immunoglobulin G following recovery from COVID-19
    Ali, A. M.
    Ali, K. M.
    Fatah, M. H.
    Tawfeeq, H. M.
    Rostam, H. M.
    NEW MICROBES AND NEW INFECTIONS, 2021, 43
  • [8] Risk of SARS-COV-2 infection following initial COVID-19 vaccination by location
    Tadrous, Mina
    Chu, Cherry
    Campbell, Tonya
    Juurlink, Dave
    Kwong, Jeff
    Paterson, Michael
    Gomes, Tara
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 : 621 - 622
  • [9] The Complexity of SARS-CoV-2 Infection and the COVID-19 Pandemic
    da Silva Torres, Maria Karoliny
    Bichara, Carlos David Araujo
    de Almeida, Maria de Nazare do Socorro
    Vallinoto, Mariana Cayres
    Queiroz, Maria Alice Freitas
    Vallinoto, Izaura Maria Vieira Cayres
    dos Santos, Eduardo Jose Melo
    de Carvalho, Carlos Alberto Marques
    Vallinoto, Antonio Carlos R.
    FRONTIERS IN MICROBIOLOGY, 2022, 13
  • [10] Models for COVID-19 Early Cardiac Pathology Following SARS-CoV-2 Infection
    Fremont-Smith, Maurice
    Gherlone, Nicole
    Smith, Nora
    Tisdall, Philip
    Ricke, Darrell O.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2021, 113 : 331 - 335